Senate Bill No. 962
Special Act No. 17-2
AN ACT CONCERNING THE DEVELOPMENT OF EVALUATIVE METRICS FOR BIOSCIENCE INVESTMENTS IN THE STATE.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. (Effective from passage) Connecticut Innovations, Incorporated shall contract with a private vendor to develop, not later than January 1, 2018, a set of metrics to evaluate the relationship between the state's investments in bioscience and the economic outcomes resulting from such investments, including, but not limited to, increased employment and any multiplier effects. Not later than thirty days after the development of such metrics is completed, Connecticut Innovations, Incorporated shall, in accordance with the provisions of section 11-4a of the general statutes, submit a report on the metrics developed pursuant to this section to the joint standing committee of the General Assembly having cognizance of matters relating to commerce.